Royal Bank Of Canada Intellia Therapeutics, Inc. Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 114,134 shares of NTLA stock, worth $1.74 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

114,134

Previous 114,716 0.51%

Holding current value

$1.74 Million

Previous $2.57 Million 8.65%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$19.72 - $27.36 $11,477 - $15,923	-582 Reduced 0.51%	114,134 $2.35 Million
Q2 2024 Aug 14, 2024	SELL	$20.02 - $27.22 $7,687 - $10,452	-384 Reduced 0.33%	114,716 $2.57 Million
Q1 2024 Nov 05, 2024	BUY	$23.82 - $32.8 $9,146 - $12,595	384 Added 0.33%	115,100 $3.17 Million
Q1 2024 May 15, 2024	SELL	$23.82 - $32.8 $917,355 - $1.26 Million	-38,512 Reduced 25.07%	115,100 $3.17 Million
Q4 2023 Feb 14, 2024	BUY	$23.16 - $32.34 $1.62 Million - $2.27 Million	70,056 Added 83.84%	153,612 $4.68 Million
Q3 2023 Nov 14, 2023	BUY	$31.62 - $45.78 $1.59 Million - $2.3 Million	50,344 Added 151.58%	83,556 $2.64 Million
Q2 2023 Aug 14, 2023	BUY	$34.58 - $46.03 $184,864 - $246,076	5,346 Added 19.18%	33,212 $1.35 Million
Q1 2023 May 15, 2023	SELL	$33.3 - $44.82 $278,254 - $374,515	-8,356 Reduced 23.07%	27,866 $1.04 Million
Q4 2022 Feb 14, 2023	BUY	$33.21 - $62.69 $569,551 - $1.08 Million	17,150 Added 89.92%	36,222 $1.26 Million
Q3 2022 Nov 14, 2022	SELL	$53.92 - $71.7 $64,919 - $86,326	-1,204 Reduced 5.94%	19,072 $1.07 Million
Q2 2022 Aug 15, 2022	SELL	$38.49 - $76.21 $401,489 - $794,946	-10,431 Reduced 33.97%	20,276 $1.05 Million
Q1 2022 May 16, 2022	SELL	$58.27 - $118.99 $70,273 - $143,501	-1,206 Reduced 3.78%	30,707 $2.23 Million
Q4 2021 Feb 14, 2022	BUY	$100.76 - $138.36 $823,410 - $1.13 Million	8,172 Added 34.42%	31,913 $3.78 Million
Q3 2021 Nov 15, 2021	BUY	$132.37 - $176.78 $155,931 - $208,246	1,178 Added 5.22%	23,741 $3.18 Million
Q2 2021 Aug 16, 2021	BUY	$60.88 - $161.91 $1.37 Million - $3.65 Million	22,563 New	22,563 $3.65 Million

Others Institutions Holding NTLA

# of Institutions

315

Shares Held

91.5M

Call Options Held

442K

Put Options Held

880K

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $1.16B
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Intellia Therapeutics, Inc. Transaction History